Benefiting from the combined analysis with functional modules, the method also allowed us to identify less frequently mutated drivers such as MED23, FOXA1, PIK3R1, and genes previously not implicated in breast cancer such as MTOR (we consider genes not reported in [23] as novel in breast cancer). The gene discussed is FOXA1; the disease is breast carcinoma.